Differentiating children with sepsis with and without acute respiratory distress syndrome using proteomics
- PMID: 34984927
- PMCID: PMC8873032
- DOI: 10.1152/ajplung.00164.2021
Differentiating children with sepsis with and without acute respiratory distress syndrome using proteomics
Abstract
Both sepsis and acute respiratory distress syndrome (ARDS) rely on imprecise clinical definitions leading to heterogeneity, which has contributed to negative trials. Because circulating protein/DNA complexes have been implicated in sepsis and ARDS, we aimed to develop a proteomic signature of DNA-bound proteins to discriminate between children with sepsis with and without ARDS. We performed a prospective case-control study in 12 children with sepsis with ARDS matched to 12 children with sepsis without ARDS on age, severity of illness score, and source of infection. We performed co-immunoprecipitation and downstream proteomics in plasma collected ≤ 24 h of intensive care unit admission. Expression profiles were generated, and a random forest classifier was used on differentially expressed proteins to develop a signature which discriminated ARDS. The classifier was tested in six independent blinded samples. Neutrophil and nucleosome proteins were over-represented in ARDS, including two S100A proteins, superoxide dismutase (SOD), and three histones. Random forest produced a 10-protein signature that accurately discriminated between children with sepsis with and without ARDS. This classifier perfectly assigned six independent blinded samples as having ARDS or not. We validated higher expression of the most informative discriminating protein, galectin-3-binding protein, in children with ARDS. Our methodology has applicability to isolation of DNA-bound proteins from plasma. Our results support the premise of a molecular definition of ARDS, and give preliminary insight into why some children with sepsis, but not others, develop ARDS.
Keywords: ARDS; DAMPs; PARDS; damage-associated molecular patterns; histones.
Conflict of interest statement
N. Yehya’s institution receives funding from Pfizer outside of the scope of this manuscript. None of the other authors has any conflicts of interest, financial or otherwise, to disclose.
Figures



Similar articles
-
The value of circulating long non-coding RNA maternally expressed gene 3 as a predictor of higher acute respiratory distress syndrome risk and 28-day mortality in sepsis patients.J Clin Lab Anal. 2020 Nov;34(11):e23488. doi: 10.1002/jcla.23488. Epub 2020 Aug 26. J Clin Lab Anal. 2020. PMID: 32844492 Free PMC article.
-
Urine-based multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS.Mol Med. 2023 Jan 26;29(1):13. doi: 10.1186/s10020-023-00609-6. Mol Med. 2023. PMID: 36703108 Free PMC article.
-
The epidemiology of acute respiratory distress syndrome in patients presenting to the emergency department with severe sepsis.Shock. 2013 Nov;40(5):375-81. doi: 10.1097/SHK.0b013e3182a64682. Shock. 2013. PMID: 23903852 Free PMC article.
-
Sepsis and Pediatric Acute Respiratory Distress Syndrome.J Pediatr Intensive Care. 2019 Mar;8(1):32-41. doi: 10.1055/s-0038-1676133. Epub 2018 Dec 10. J Pediatr Intensive Care. 2019. PMID: 31073506 Free PMC article. Review.
-
Personalized medicine using omics approaches in acute respiratory distress syndrome to identify biological phenotypes.Respir Res. 2022 Nov 19;23(1):318. doi: 10.1186/s12931-022-02233-0. Respir Res. 2022. PMID: 36403043 Free PMC article. Review.
Cited by
-
PAMPs and DAMPs in Sepsis: A Review of Their Molecular Features and Potential Clinical Implications.Int J Mol Sci. 2024 Jan 12;25(2):962. doi: 10.3390/ijms25020962. Int J Mol Sci. 2024. PMID: 38256033 Free PMC article. Review.
-
The critical role of neutrophil-endothelial cell interactions in sepsis: new synergistic approaches employing organ-on-chip, omics, immune cell phenotyping and in silico modeling to identify new therapeutics.Front Cell Infect Microbiol. 2024 Jan 8;13:1274842. doi: 10.3389/fcimb.2023.1274842. eCollection 2023. Front Cell Infect Microbiol. 2024. PMID: 38259971 Free PMC article. Review.
-
Sepsis subphenotypes: bridging the gaps in sepsis treatment strategies.Front Immunol. 2025 Feb 6;16:1546474. doi: 10.3389/fimmu.2025.1546474. eCollection 2025. Front Immunol. 2025. PMID: 40013154 Free PMC article. Review.
-
Emerging Roles of Galectin-3 in Pulmonary Diseases.Lung. 2024 Aug;202(4):385-403. doi: 10.1007/s00408-024-00709-y. Epub 2024 Jun 8. Lung. 2024. PMID: 38850292 Review.
References
-
- Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for sepsis and septic shock (sepsis-3). JAMA 315: 801–810, 2016. doi:10.1001/jama.2016.0287. - DOI - PMC - PubMed
-
- Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, Ranieri M, Rubenfeld G, Thompson BT, Wrigge H, Slutsky AS, Pesenti A, Investigators LS, Group ET; ESICM Trials Group. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315: 788–800, 2016. doi:10.1001/jama.2016.0291. - DOI - PubMed
-
- Khemani RG, Smith L, Lopez-Fernandez YM, Kwok J, Morzov R, Klein MJ, Yehya N, Willson D, Kneyber MCJ, Lillie J, Fernandez A, Newth CJL, Jouvet P, Thomas NJ, Pediatric Acute Respiratory Distress Syndrome I, Epidemiology I, Pediatric Acute Lung I, Sepsis Investigators N; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study. Lancet Respir Med 7: 115–128, 2019. doi:10.1016/S2213-2600(18)30344-8. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous